The rising prevalence of obesity is creating the need for the use of personalized nutrition. .Furthermore, the use of nutrigenomics and lifestyle genomics in clinical practice has the potential to optimize weight-related outcomes for patients. In addition, telehealth, e-healthcare services, and the integration of nutrigenomics and AI will present immense opportunities for the nutrigenomics testing market players. Thus, as the prevalence of obesity continue to increase at a higher rate, the demand of nutrigenomics testing is anticipated to grow in the future.
According to the report, the global nutrigenomics market generated $435.7 million in 2022, and is anticipated to generate $2.1 billion by 2032, rising at a CAGR of 17.2% from 2023 to 2032.
The rising prevalence of chronic diseases, advancements in nutrigenomics testing, and growing awareness of personalized nutrition among people across the globe are the factors expected to drive the growth of the global nutrigenomics market in the forecast period from 2023 to 2032. However, limited awareness and government regulation regarding genetic research or testing may hamper market growth in the coming future. On the contrary, the expansion of direct-to-consumer nutrigenomics services and the integration of nutrigenomics in healthcare systems are expected to offer remunerative opportunities for the expansion of the nutrigenomics market during the forecast period.
Request Sample of the Report on –
Product Type: Reagents and Kits Sub-segment to Flourish Immensely by 2032
The reagents and kits sub-segment accounted for the largest global nutrigenomics market share of 65.1% in 2022 and is expected to grow at the highest CAGR of 17.5% during the forecast period from 2023 to 2032. This is mainly due to the increase in number of chronic diseases and personalization of diet to prevent diseases due to unhealthy lifestyle and dietary change. Besides, the rising adoption of telehealth services that include pharmacy services, online medical visits, and memberships is driving the demand for reagents & kits.
Applications: Obesity Sub-segment to Dominate During the Forecast Period
The obesity sub-segment accounted for the largest market share of 37.0% in 2022 and is expected to the highest grow at a CAGR of 18.1% during the forecast period. This is mainly due to the increasing overweight population across the globe. The World Obesity Federation’s 2023 Atlas anticipates that more than 4 billion people, constituting 51% of the global population, will be either obese or overweight in the next 12 years.
End User: Hospitals & Clinics Sub-segment to Hold Major Market Share by 2032
The hospitals & clinics sub-segment of the global market accounted for the highest share of 46.8% in 2022 and is projected to continue to hold major market share by 2032. This is mainly owing to the rapidly evolving and uncertain regulatory landscape of telehealth. The presence of medical professionals in hospitals and clinics ensures accurate sample collection, result interpretation, and effective communication of findings to patients. This professional expertise enhances the credibility of nutrigenomic testing.
Region: North America Market to be the Most Dominant During the Forecast Period
The nutrigenomics market in the North America region accounted for the largest share of 43.9% in 2022 and is predicted to be dominant and grow at the highest CAGR of 18.0% during the forecast period. This growth is mainly due to growing health disorders in the region. In addition, companies in North America are releasing genetic reports for their subscribers, which is contributing towards nutrigenomics research. Moreover, the presence of major nutrigenomics companies in the region is expected to generate opportunities in the nutrigenomics testing market in the coming years.
For Procurement Information –
Leading Players in the Nutrigenomics market:
Nutrigenomix Inc.
Metagenics, Inc.
The Gene Box
DNA Life
GX Sciences Inc.
Genova Diagnostics
Holistic Health
Cura Integrative Medicine
Xcode Life
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]
Web: https://www.alliedmarketresearch.com
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
This release was published on openPR.
link